Literature DB >> 30678976

Synthesis and characterization of Zinc oxide nanoparticles utilizing seed source of Ricinus communis and study of its antioxidant, antifungal and anticancer activity.

N Shobha1, N Nanda2, Aladahalli Shivanna Giresha3, Praveen Manjappa4, Sophiya P3, K K Dharmappa3, B M Nagabhushana4.   

Abstract

ZnO nanoparticles have been synthesized using solution combustion technique and its antioxidant, antifungal, anticancer activity was studied. Ricinus communis plant seed extract used as fuel in synthesis by the solution combustion technique. Powder X-ray diffraction (PXRD) demonstrates the arrangement of a crystalline hexagonal stage (ICDD card number 89-1397) with space aggregate P63mc (186) and cell parameters a = b = 3.253, c = 5.213 Å. The normal crystallite measure is 20 nm which is ascertained by Debye - Scherer's formula. The Purity of the sample and metal to oxygen bond development was affirmed by utilizing Fourier transformation infrared (FTIR) spectroscopy and the particle size and shape was confirmed by HRTEM. Antifungal action of ZnO NPs was studied against Aspergillus and Penicillium by well dispersion strategy. The antifungal activity shows that ZnO NPs constitute as an effective fungicidal agent against both Aspergillus (4 ± 0.5 mm) and Penicillium (3 mm ± 0.4 mm) at 30 μg/mL fixation. ZnO nanoparticles were subjected to antioxidant activity. The objective of the study was to analyze the anticancer property of ZnO NPs on MDA-MB 231 cancer cells. To check the efficacy of the synthesized drug ZnO NPs MTT assay was performed, that determines % viability and/or cytotoxicity. IC50 of ZnO NPs in case of MDA-MB-231 breast cancer was 7.103 μg/mL. Anticancer outcome demonstrates that ZnO NPs is active against in MDA-MB-231 cells.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antifungal; Antioxidant; Aspergillus and Penicillium; MDA-MB-231; MTT assay; Ricinus communis; Solution combustion

Mesh:

Substances:

Year:  2018        PMID: 30678976     DOI: 10.1016/j.msec.2018.12.023

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  5 in total

Review 1.  A Critical Review of the Antimicrobial and Antibiofilm Activities of Green-Synthesized Plant-Based Metallic Nanoparticles.

Authors:  Miryam M Luzala; Claude K Muanga; Joseph Kyana; Justin B Safari; Eunice N Zola; Grégoire V Mbusa; Yannick B Nuapia; Jean-Marie I Liesse; Christian I Nkanga; Rui W M Krause; Aistė Balčiūnaitienė; Patrick B Memvanga
Journal:  Nanomaterials (Basel)       Date:  2022-05-27       Impact factor: 5.719

Review 2.  Nanoparticles: Synthesis, Morphophysiological Effects, and Proteomic Responses of Crop Plants.

Authors:  Zahed Hossain; Farhat Yasmeen; Setsuko Komatsu
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 3.  Current Research on Zinc Oxide Nanoparticles: Synthesis, Characterization, and Biomedical Applications.

Authors:  Ashok Kumar Mandal; Saurav Katuwal; Felix Tettey; Aakash Gupta; Salyan Bhattarai; Shankar Jaisi; Devi Prasad Bhandari; Ajay Kumar Shah; Narayan Bhattarai; Niranjan Parajuli
Journal:  Nanomaterials (Basel)       Date:  2022-09-03       Impact factor: 5.719

4.  Mycogenic Synthesis of Extracellular Zinc Oxide Nanoparticles from Xylaria acuta and Its Nanoantibiotic Potential.

Authors:  Basavaraju Sumanth; Thimappa Ramachandrappa Lakshmeesha; Chowdappa Srinivas; Mohammad Azam Ansari; Mohammad A Alzohairy; Arakere Chunchegowda Udayashankar; Balagangadharaswamy Shobha; Siddapura Ramachandrappa Niranjana; Ahmad Almatroudi
Journal:  Int J Nanomedicine       Date:  2020-11-02

Review 5.  Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview.

Authors:  Vijayakumar Shrihastini; Pandiyan Muthuramalingam; Sivakumar Adarshan; Mariappan Sujitha; Jen-Tsung Chen; Hyunsuk Shin; Manikandan Ramesh
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.